(Q43880096)

English

Long-term treatment with nipradilol, a nitric oxide-releasing beta-adrenergic blocker, enhances postischemic recovery and limits infarct size

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Long-term treatment with nipradilol, a nitric oxide-releasing beta-adrenergic blocker, enhances postischemic recovery and limits infarct size (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Yoshihiro Suematsu

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Toshiya Ohtsuka

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Hitoshi Horimoto

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Katsuhide Maeda

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Yasunari Nakai

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Shigetoshi Mieno

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Shinichi Takamoto

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

The Annals of Thoracic Surgery

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

73

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

173-179

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

The beta adrenoreceptor antagonist, nipradilol, preserves the endothelial nitric oxide response in atherosclerotic vessels of rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: A novel mechanism of action of beta-blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Nitric oxide-generating beta-adrenergic blocker nipradilol preserves postischemic cardiac function

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Pharmacokinetics of nipradilol (K-351), a new antihypertensive agent. I. Studies on interspecies variation in laboratory animals.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Cardiovascular effects of nipradilol, a beta-adrenoceptor blocker with vasodilating properties

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Normothermic transfer times up to 3 min will not precondition the isolated rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

L-Arginine given after ischaemic preconditioning can enhance cardioprotection in isolated rat hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Inhibition of nitric oxide synthase and soluble guanylate cyclase induces cardiodepressive effects in normal rat hearts.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Cyclic GMP elevation by 5-hydroxytryptamine is due to nitric oxide derived from endogenous nitrosothiol in NG108-15 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Effect of nipradilol, a new beta-blocker, on leukotriene D4-induced contraction in guinea pig tracheal smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Cyclic GMP regulates the Ca-channel current in guinea pig ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Control of cardiac muscle cell function by an endogenous nitric oxide signaling system

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

The role of nitric oxide in cardiac ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Ischemic Preconditioning against Arrhythmias: An Anti-Arrhythmic or an Anti-Ischemic Phenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Adenosine preconditioning of human myocardium is dependent upon the ATP-sensitive K+ channel

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Pharmacologic preconditioning induced by beta-adrenergic stimulation is mediated by activation of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Ischemic preconditioning and the beta-adrenergic signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Adenosine-enhanced ischemic preconditioning provides enhanced cardioprotection in the aged heart

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

The L-arginine-nitric oxide pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903234-9

7 January 2021

Identifiers

10.1016/S0003-4975(01)03234-9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43880096&oldid=2104114822"